Fight Colorectal Cancer (Fight CRC) and Roche’s Flatiron Health have teamed up to design a clinical trials app finder. The team have collaborated to design and build an app addressing late-stage MSS-CRC clinical trial finder reports Newswise.
Reported to be a first-of-its-kind, it is now available for both iOS and Android-based smart phones. It enables patients with late stage Microsatellite Stable (MSS) colorectal cancer to research relevant clinical trials via their phone.
The actual application (Fight CRC Clinical Trial Finder) was designed by an actual state IV colorectal cancer survivor—Dr. Tom Marsilje. Dr. Marsilje originally developed the idea using a spreadsheet. As word spread about his curated clinical trials list he decided to make it easier for others to search for clinical trials. In 2017 he was offered the opportunity to partner with Fight CRC and Flatiron Health to progress the tool to a modernized app.
Flatiron (acquired and part of Swiss-based Roche) developed the web-based version of the Clinical Trial Finder during a “hackathon.” Thereafter the team continued to progress the product. Since 2017, nearly 14,000 people have utilized the tool equaling over 24,000 unique clinical trial searches.
About Fight CRC
A trusted national nonprofit advocacy organization fight for a cure to colorectal cancer. It was formed in 2005 by Nancy Roach, a patient advocate who witnessed the need for colorectal cancer advocacy after her mother-in-law’s cancer diagnosis. The organization is known for its activism, patient empowerment throughout patient, academic, political and scientific as well as medical communities.
About Flatiron Health
Acquired by Roche, they are a healthcare technology and service venture focusing on accelerating cancer research and improving patient care. They offer a platform for cancer researchers and care providers to learn more from the experience of every patient. They currently partner with over 280 community practices, sever major academic research centers and 15 top oncology companies.Source: Newswise